Plain-English translation of NCT06588855 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a new medication called to see if it can help people with moderate to severe ulcerative colitis—a condition where the colon becomes inflamed and causes pain, bleeding, and diarrhea. Half of the participants will receive the medication through an IV injection followed by shots under the skin, while the other half will receive a placebo (a dummy treatment) to compare results. Researchers want to find out if this treatment is safe and actually works better than placebo for people whose ulcerative colitis hasn't improved with other therapies.
Ulcerative colitis can be very hard to control with current treatments, and many patients don't get relief from standard medications. This trial exists to see if this new medication offers hope for people who have already tried other treatments without success.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive either the new medication or a placebo. You'll start with an IV injection, then continue with injections under your skin. Throughout the study, you'll have regular visits to the clinic where doctors will check how you're doing, run blood tests, and assess whether your ulcerative colitis symptoms are improving. The study team will carefully monitor you for any side effects and track how well the treatment is working.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
United States